A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and Maintenance Gefitinib for Patients with Stage III Non-small Cell Lung Cancer
Publication
, Journal Article
Center, B; Petty, WJ; Ayala, D; Hinson, WH; Lovato, J; Capellari, J; Oaks, T; Miller, AA; Blackstock, AW
Published in: Journal of Thoracic Oncology
January 2010
Duke Scholars
Published In
Journal of Thoracic Oncology
DOI
ISSN
1556-0864
Publication Date
January 2010
Volume
5
Issue
1
Start / End Page
69 / 74
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Center, B., Petty, W. J., Ayala, D., Hinson, W. H., Lovato, J., Capellari, J., … Blackstock, A. W. (2010). A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and Maintenance Gefitinib for Patients with Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology, 5(1), 69–74. https://doi.org/10.1097/jto.0b013e3181c59a0e
Center, Brian, William Jeffrey Petty, Diandra Ayala, William H. Hinson, James Lovato, James Capellari, Timothy Oaks, Antonius A. Miller, and Arthur William Blackstock. “A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and Maintenance Gefitinib for Patients with Stage III Non-small Cell Lung Cancer.” Journal of Thoracic Oncology 5, no. 1 (January 2010): 69–74. https://doi.org/10.1097/jto.0b013e3181c59a0e.
Center B, Petty WJ, Ayala D, Hinson WH, Lovato J, Capellari J, et al. A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and Maintenance Gefitinib for Patients with Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 2010 Jan;5(1):69–74.
Center, Brian, et al. “A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and Maintenance Gefitinib for Patients with Stage III Non-small Cell Lung Cancer.” Journal of Thoracic Oncology, vol. 5, no. 1, Elsevier BV, Jan. 2010, pp. 69–74. Crossref, doi:10.1097/jto.0b013e3181c59a0e.
Center B, Petty WJ, Ayala D, Hinson WH, Lovato J, Capellari J, Oaks T, Miller AA, Blackstock AW. A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and Maintenance Gefitinib for Patients with Stage III Non-small Cell Lung Cancer. Journal of Thoracic Oncology. Elsevier BV; 2010 Jan;5(1):69–74.
Published In
Journal of Thoracic Oncology
DOI
ISSN
1556-0864
Publication Date
January 2010
Volume
5
Issue
1
Start / End Page
69 / 74
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology